Serum Hepcidin Immunoassay - Laboratory to Marketplace

Completed

Conditions studied: Anemia, Iron Deficiency

In brief

This is a single center, prospective, observational study to demonstrate the clinical validity of the Intrinsic LifeSciences (ILS) Intrinsic Hepcidin IDx™ Test in the diagnosis and management of iron deficiency (ID) in adolescents and young adults. This test is considered non-significant risk.

Key facts

Study ID
NCT03310736
Run by
Intrinsic LifeSciences, LLC
People needed
494
Starts
2016-06-30
Expected to finish
2019-02-28
Last updated by the study team
2019-06-18

Who can join

Age: 11 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.